Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Eliminating Use of Non Depolarizing Neuromuscular Blocking Agents to Reduce Postoperative Pulmonary Complications: A Multi-center, Randomized Control Trial

To see complete record on, please visit this link

Id: NCT03962725

Organisation Name: Beth Israel Deaconess Medical Center

Overal Status: Suspended

Start Date: August 7, 2019

Last Update: April 28, 2020

Lead Sponsor: Beth Israel Deaconess Medical Center

Brief Summary: The goal of this study to evaluate whether eliminating the use of non-depolarizing neuromuscular blocking agents (NMBA) for maintenance of general anesthesia reduces postoperative pulmonary complications in higher risk patients.

  • Respiratory Failure
  • Respiratory Infection
  • Aspiration Pneumonia
  • Pneumonitis
  • Atelectasis
  • Bronchospasm

Total execution time in seconds: 0.31382298469543